Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

Items 51-60 of 122

Page
per page
  1. A 366
    B4947 A 366
    Summary: G9a/GLP histone lysine methyltransferase inhibitor
  2. Sephin1
    A8708 Sephin1
     1 Citation
    Target: phosphatases
    Summary: Selective PPP1R15A inhibitor
      insoluble in H2O; insoluble in EtOH; ≥7.75 mg/mL
  3. Chidamide
    B5916 Chidamide
     1 Citation
    Target: HDAC
    Summary: Novel HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.55 mg/mL
  4. Rucaparib (free base)
    A8893 Rucaparib (free base)
    Target: PARP
    Summary: Potent PARP inhibitor
      insoluble in H2O; insoluble in EtOH; ≥16.15 mg/mL
  5. HPOB
    B4890 HPOB
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor, potent and selective
      ≥31.4 mg/mL
  6. YM 750
    B7250 YM 750
    Summary: Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor
      <45.26 mg/mL
  7. L002
    B7739 L002
    Summary: p300 inhibitor
      Soluble in DMSO
  8. Tautomycetin
    B7009 Tautomycetin
    Summary: A novel and specific protein phosphatase 1 (PP1) inhibitor
      Soluble in DMSO (supplied pre-dissolved in DMSO
  9. MK-4827
    A3617 MK-4827
    Target: PARP
    Summary: PARP-1/-2 inhibitor,potent and selective
      ≥32 mg/mL
  10. IOX2(Glycine)
    A4189 IOX2(Glycine)
     1 Citation
    Summary: HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor
      insoluble in EtOH; insoluble in H2O; ≥17.6 mg/mL

Items 51-60 of 122

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 7item
  2. Aurora Kinase 13item
  3. DNA Methyltransferase 4item
  4. HDAC 16item
  5. Histone Acetyltransferases 3item
  6. Histone Demethylases 3item
  7. Histone Methyltransferase 15item
  8. HIF 4item
  9. JAK 19item
  10. PARP 17item
  11. Pim 6item
  12. Protein Ser/Thr Phosphatases 10item
  13. Sirtuin 3item
  14. Sphingosine Kinase-2 1 item
  15. Polycomb repressive complex 1 item
  16. SUMOylation 1 item
Specificity
  1. Selective 43item
Reversibility
  1. Reversible 3item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 12item
  3. PI3K 1 item
  4. Aurora Kinases 8item
  5. EZH2 2item
  6. Bromodomains 4item
  7. FLT3 1 item
  8. PLK 1 item
  9. MEK 1 item
  10. DOT1L 1 item
  11. FGFR 1 item
  12. Pim 1 item
  13. Sir2-like Family Deacetylases (Sirtuins) 1 item
  14. Src 1 item
  15. STAT 2item
  16. JAK 12item
  17. EZH1 1 item
  18. TNKS 1 item
  19. DNA Methyltransferases 2item
  20. SMYD2 1 item
  21. PARP 5item
  22. phosphatases 1 item
  23. G9a 1 item
  24. SETD7 1 item
  25. MNK 1 item
  26. Cytidine deaminases 1 item
  27. c-RET 1 item
  28. p53 1 item
  29. HDAC 1 item
  30. KDM 1 item
  31. Histone Acetyltransferases (HATs) 1 item
  32. Lck 1 item
  33. p21 1 item
  34. PHF 1 item
  35. SK 1 item
Reported Experiments
  1. Animal Experiments 47item
  2. Cell Experiments 39item
Related Disease
  1. Acute Myeloid Leukemia 3item
  2. Bladder Carcinoma 1 item
  3. Breast Cancer 10item
  4. Cancer 34item
  5. Castration-resistant Prostate Cancer 1 item
  6. Cervical Cancer 2item
  7. Colon Cancer 5item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 1 item
  10. Diabetes 1 item
  11. Diffuse Large B-cell Lymphoma 1 item
  12. Glioblastoma 1 item
  13. Glioma 2item
  14. Hepatocellular Carcinoma 1 item
  15. HIV 2item
  16. HIV Infections 1 item
  17. Immunological Diseases 1 item
  18. Inflammatory Bowel Disease 1 item
  19. Inflammatory Diseases 2item
  20. Leukemia 3item
  21. Lung Cancer 3item
  22. Lymphoma 1 item
  23. Melanoma 1 item
  24. Mixed Lineage Leukemia 1 item
  25. Multiple Myeloma 3item
  26. Myelofibrosis 1 item
  27. Myeloma 1 item
  28. Non-small Cell Lung Cancer 3item
  29. Ovarian Cancer 1 item
  30. Pancreatic Cancer 2item
  31. Prostate Cancer 6item
  32. Psoriasis 1 item
  33. Renal Cell Carcinoma 1 item
  34. Rheumatoid Arthritis 3item